Your browser doesn't support javascript.
loading
Therapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trials.
Cottin, Vincent; Azuma, Arata; Raghu, Ganesh; Stansen, Wibke; Stowasser, Susanne; Schlenker-Herceg, Rozsa; Kolb, Martin.
Afiliação
  • Cottin V; National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, Lyon, France vincent.cottin@chu-lyon.fr.
  • Azuma A; Nippon Medical School, Tokyo, Japan.
  • Raghu G; University of Washington, Seattle, WA, USA.
  • Stansen W; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.
  • Stowasser S; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
  • Schlenker-Herceg R; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA.
  • Kolb M; McMaster University, Hamilton, ON, Canada.
Eur Respir J ; 53(4)2019 04.
Article em En | MEDLINE | ID: mdl-30655282
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Enfisema / Fibrose Pulmonar Idiopática / Indóis Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteínas Quinases / Enfisema / Fibrose Pulmonar Idiopática / Indóis Idioma: En Ano de publicação: 2019 Tipo de documento: Article